Anatomic Pathology Market Scope And Analysis

Report Code : TIPRE00002999
Category : Life Sciences

Status : Published
No. of Pages : 178

Buy Now

Anatomic Pathology Market Report Scope 2021 to 2031

Buy Now

Anatomic Pathology Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 30.22 Billion
Market Size by 2031	US$ 53.27 Billion
Global CAGR (2023 - 2031)	7.3%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Product and Services Services Instruments Consumables By Application Disease Diagnosis Drug Discovery and Development By End User Hospitals Research Laboratories Diagnostic Laboratories
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	F Hoffmann La Roche Ltd Beckman Coulter Inc Hologic Inc Agilent Technologies Inc BioGenex Laboratories Inc Diapath S p A Bio SB Merck KGaA BD PHC Holdings Corporation

Anatomic Pathology Market News and Recent Developments

The anatomic pathology market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:

Agilent Technologies Inc. partnered with Hamamatsu Photonics K.K., a leading provider of whole slide imaging systems. The collaboration involved incorporating Hamamatsu's NanoZoomer range, including the S360MD Slide scanner system, into Agilent's digital pathology solution. The addition of the NanoZoomer Slide scanner systems, which convert glass slides into high-resolution digital data through high-speed scanning, has completed Agilent's offering of an open and agnostic digital pathology workflow aimed at accelerating breakthroughs in precision medicine. (Source: Agilent Technologies Inc., Company Website, March 2023)
Epredia, a subsidiary of PHC Corporation, and NovaScan, Inc., a company that develops breakthrough technology for cancer detection and stratification, announced signing a letter of intent for a U.S. exclusive commercial distribution agreement for MarginScan, a medical device that will support physicians in real-time detection of non-melanoma skin cancer. Epredia has engaged Avantik, a company specializing in supporting diagnostic labs with their operations, to get this new device into the hands of Mohs surgeons. (Source: PHC Corporation, Company Website, May 2024)

Anatomic Pathology Market Report Coverage and Deliverables

The "Anatomic Pathology Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

Anatomic pathology market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Anatomic pathology market trends, as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PESTand SWOT analysis
Anatomic pathology market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the anatomic pathology market
Detailed company profiles